患者决策辅助工具能否降低乳腺癌放疗降阶梯试验中的决策冲突:PRIMETIME 嵌入式试验
PRIMETIME 是一项评估极低局部复发风险早期乳腺癌患者省略辅助放疗的生物标志物导向研究,其嵌入式 SWAT 采用整群阶梯楔形设计,比较标准信息与增强信息(加视频)对决策冲突的影响。
要点
- 标准组与增强组决策冲突评分均低,组间差异无统计学意义。
- 增强信息组仅 36% 患者报告观看了视频,依从性有限。
- 低决策冲突可能反映高质量信息提供,并非所有患者都需要视频。
核心结论
- 在 PRIMETIME 试验中,增强信息(标准信息加视频)未显著降低患者决策冲突评分。
- 两组决策冲突水平均较低,可能反映高质量信息提供已足够。
研究设计与样本
- 嵌入式 Study Within A Trial(SWAT),采用整群阶梯楔形试验设计。
- 集群为放疗中心及其转诊外周中心,所有集群起始为标准信息组,随机在 2、4 或 6 个月交叉至增强信息组。
主要发现
- 标准组(N=184)决策冲突量表平均分 10.88(SD 11.82),增强组(N=337)为 8.99(SD 11.82)。
- 均差 -1.78(95%CI -3.82-0.25,p=0.09),无统计学显著差异。
- 增强组仅 121/337(36%)报告观看了视频。
关键数值与推荐
- 主要终点为决策冲突量表(0-100,分数越高冲突越大),在个体参与者水平评估。
- 采用多水平混合效应模型,集群为随机效应,每步骤为固定效应以调整日历时间和聚类。
- 使用稳健标准误调整聚类效应。
临床怎么用
- 对于极低局部复发风险的早期乳腺癌患者,高质量标准信息可能已足够降低决策冲突。
- 视频等增强决策辅助工具并非所有患者必需,应关注信息提供的整体质量。
局限性
- 增强组视频观看率仅 36%,可能低估视频的潜在效果。
- 决策冲突评分整体较低,可能存在天花板效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: For patients with early breast cancer considered at very-low risk of local relapse, risks of radiotherapy may outweigh the benefits. Decisions regarding treatment omission can lead to patient uncertainty (decisional conflict), which may be lessened with patient decision aids (PDA). PRIMETIME (ISRCTN 41579286) is a UK-led biomarker-directed study evaluating omission of adjuvant radiotherapy in breast cancer; an embedded Study Within A Trial (SWAT) investigated whether PDA reduces decisional conflict using a cluster stepped-wedge trial design. METHODS: PDA diagrams and a video explaining risks and benefits of radiotherapy were developed in close collaboration between patient advocates and PRIMETIME trialists. The SWAT used a cluster stepped-wedge trial design, where each cluster represented the radiotherapy centre and referring peripheral centres. All clusters began in the standard information group (patient information and diagrams) and were randomised to cross-over to the enhanced information group (standard information plus video) at 2, 4 or 6 months. Primary endpoint was the decisional conflict scale (0-100, higher scores indicating greater conflict) which was assessed on an individual participant level. Multilevel mixed effects models used a random effect for cluster and a fixed effect for each step to adjust for calendar time and clustering. Robust standard errors were also adjusted for the clustering effect. RESULTS: Five hundred twenty-one evaluable questionnaires were returned from 809 eligible patients (64%) in 24 clusters between April 2018 and October 2019. Mean decisional conflict scores in the standard group (N = 184) were 10.88 (SD 11.82) and 8.99 (SD 11.82) in the enhanced group (N = 337), with no statistically significant difference [mean difference - 1.78, 95%CI - 3.82-0.25, p = 0.09]. Compliance with patient information and diagrams was high in both groups although in the enhanced group only 121/337 (36%) reported watching the video. CONCLUSION: The low levels of decisional conflict in PRIMETIME are reassuring and may reflect the high-quality information provision, such that not everyone required the video. This reinforces the importance of working with patients as partners in clinical trials especially in the development of patient-centred information and decision aids.
引用
- Bhattacharya IS, Haviland JS, Turner L, et al. Can patient decision aids reduce decisional conflict in a de-escalation of breast radiotherapy clinical trial? The PRIMETIME Study Within a Trial implemented using a cluster stepped-wedge trial design. Trials. 2021. PMID: 34127033. doi:10.1186/s13063-021-05345-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。